Protein Biomarkers May Predict Development Of Acute GVHD After Donor Stem … – The Myeloma Beacon
|
Protein Biomarkers May Predict Development Of Acute GVHD After Donor Stem …
The Myeloma Beacon Donor (allogeneic) stem cell transplantation has the potential to be a curative therapy for multiple myeloma. During the procedure, the patient receives chemotherapy and/or radiation treatment, which destroy the patient’s diseased stem cells as well as … |
